Biggest News Aggregation in the World
📰 Current Status News

Page 51 - Current Status News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Current Status. Real-time updates on events, politics, business and more.

Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the data from the pivotal Phase 3 SOLSTICE clinical trial of LIVTENCITY™ (maribavir, TAK-620) in post-transplant refractory† CMV infections with or without resistance‡ (R/R) were published in the journal of Clinical Infectious Diseases (CID).
United States Clin Virol Takeda Pharmaceuticals United States Inc International Report On Organ Donation Takeda Pharmaceutical Company Limited World Health Organization

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science